Effect of nonsurgical periodontal therapy on crevicular fluid levels of Cathepsin K in periodontitis

Archives of Oral Biology

Volumn 54, Issue 11, 2009, Pages 1046-1051

  Garg, Garima ^a   Pradeep, A R ^a   Thorat, Manoj Kumar ^a  

^a Research Institute   (India)

Author keywords

Cathepsin K; Chronic periodontitis; Gingival crevicular fluid; Gingivitis; Periodontal health; Scaling and root planing

Indexed keywords

CATHEPSIN K; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS LINKED PEPTIDE; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; CHEMISTRY; CHRONIC PERIODONTITIS; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; OSTEOBLAST; PERIODONTICS; PREVENTIVE DENTISTRY;

ADULT; ALVEOLAR BONE LOSS; CATHEPSIN K; CHRONIC PERIODONTITIS; COLLAGEN TYPE I; DENTAL SCALING; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HUMANS; MALE; OSTEOBLASTS; PEPTIDES; PERIODONTAL INDEX;

EID: 70349782108     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2009.08.007     Document Type: Article

References (28)

1. Giannobile W.V. Host-response therapeutics for periodontal diseases. J Periodontol 79 (2008) 1592-1600
2. Dickinson D.P. Cysteine peptidases of mammals: their biological roles and potential effects in the oral cavity and other tissues in health and disease. Crit Rev Oral Biol Med 13 3 (2002) 238-275
3. Zavasjnik-Bergant T., and Turk B. Cysteine cathepsins in the immune response. Tissue Antigens 67 (2006) 349-355
4. Goto T., Yamaza T., and Tanaka T. Cathepsins in the osteoclast. J Electron Microsc 52 6 (2003) 551-558
5. Ahlberg J., Berkenstam A., Henell F., and Glaumann H. Degradation of short and long lived proteins in isolated rat liver lysosomes. Effects of pH, temperature, and proteolytic inhibitors. J Biol Chem 260 (1985) 5847-5854
6. Drake F.H., Dodds R.A., James I.E., Connor J.R., Debouck C., Richardson S., et al. Cathepsin K but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem 271 (1996) 12511-12516
7. Meier C., Meinhardt U., Greenfield J.R., De Winter J., Nguyen T.V., Dunstan C.R., et al. concentrations reflect osteoclastic activity in women with postmenopausal osteoporosis and patients with Paget's disease. Clin Lab 52 (2006) 1-10
8. Montonen M., Li T.F., Lukinmaa P.L., Sakai E., Hukkanen M., Sukura A., et al. RANKL and Cathepsin K in diffuse sclerosing osteomyelitis of the mandible. J Oral Pathol Med 35 (2006) 620-625
9. Hummel K.M., Petrow P.K., Franz J.K., Muller-Ladner U., Aicher W.K., Gay R.E., et al. Cysteine proteinase Cathepsin K mRNA is expressed in synovium of patients with rheumatoid arthritis and is detected at sites of synovial bone destruction. J Rheumatol 25 (1998) 1887-1894
10. Skoumal M., Haberhauer G., Kolarz G., Hawa G., Woloszczuk W., and Klingler A. Serum Cathepsin K levels of patients with longstanding rheumatoid arthritis: correlation with radiological destruction. Arthritis Res Ther 7 (2005) R65-R70
11. Wendling D., Cedoz J.-P., and Racadot E. Serum levels of MMP-3 and Cathepsin K in patients with ankylosing spondylitis: effect of TNFα antagonist therapy. Joint Bone Spine 75 (2008) 559-562
12. Lutgens E., Lutgens S.P., Faber B.C., Heeneman S., Gijbels M.M., de Winther M.P., et al. Disruption of the Cathepsin K gene reduces atherosclerosis progression and induces plaque fibrosis but accelerates macrophage foam cell formation. Circulation 113 (2006) 98-107
13. Hie M., Shimono M., Fujii K., and Tsukamoto I. Increased Cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone 41 (2007) 1045-1050
14. Joyce J.A., Baruch A., Chehade K., Meyer-Morse N., Giraudo E., Tsai F.Y., et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 5 (2004) 443-453
15. Rocken C., Fandrich M., Stix B., Tannert A., Hortschansky P., Reinheckel T., et al. Cathepsin protease activity modulates amyloid load in extracerebral amyloidosis. J Pathol 210 (2006) 478-487
16. Yin X., Han J., Luo T., Wang L., Chen S., Zhao Y., et al. Adipocyte differentiation and its potential role in the pathogenesis of obesity. J Clin Endocrinol Metab 91 (2006) 4520-4527
17. Everts V., Hou W.S., Rialland X., Tigchelaar W., Saftig P., Bromme D., et al. Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts. Calcif Tissue Int 73 (2003) 380-386
18. Ohba Y., Ohba T., Terai K., and Moriyama K. Expression of Cathepsin K mRNA during experimental tooth movement in rat as revealed by in situ hybridization. Arch Oral Biol 45 (2000) 63-69
19. Strbac G.D., Monov G., Cei S., Kandler B., Watzek G., Gruber R., et al. levels in the crevicular fluid of dental implants: a pilot study. J Clin Periodontol 33 (2006) 302-308
20. Mogi M., and Otogoto J. Expression of cathepsin-K in gingival crevicular fluid of patients with periodontitis. Arch Oral Biol 52 (2007) 894-898
21. Loe H., and Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 21 (1963) 533
22. Griffiths G.S. Formation, collection and significance of gingival crevicular fluid. Periodontol 2000 31 (2003) 32-42
23. Pentikainen M.O., Oorni K., Ala-Korpela M., and Kovanen P.T. Modified LDL trigger of atherosclerosis and inflammation in the arterial intima. J Int Med 247 (2000) 359-370
24. Runger T.M., Quintanilla-Dieck M.J., and Bhawan J. Role of Cathepsin K in the turnover of the dermal extracellular matrix during scar formation. J Invest Dermatol 127 (2007) 293-297
25. Yasuda Y., Kaleta J., and Bromme D.T. The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics. Adv Drug Deliv Rev 57 (2005) 973-993
26. Kafienah W., Bromme D., Buttle D.J., Croucher L.J., and Hollander A.P. Human Cathepsin K cleaves native type I and II collagens at the N-terminal end of the triple helix. Biochem J 331 (1998) 727-732
27. Sassi M.L., Eriksen H., Risteli L., Niemi S., Mansell J., Gowen M., et al. Immunochemical characterization of assay for carboxyterminal telopeptide of human type I collagen: loss of antigenicity by treatment with Cathepsin K. Bone 26 (2000) 367-373
28. Stroup G.B., Lark M.W., Veber D.F., Bhattacharyya A., Blake S., Dare L.C., et al. Potent and selective inhibition of human Cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primate. J Bone Miner Res 16 (2001) 1739-1746